Marimed (MRMD) Operating Expenses (2011 - 2026)

Marimed (MRMD) has 16 years of Operating Expenses data on file, last reported at $15.2 million in Q1 2026.

• On a quarterly basis, Operating Expenses fell 5.3% year-over-year to $15.2 million in Q1 2026; TTM through Mar 2026 was $59.8 million, a 2.73% decrease from a year earlier, with the FY2025 full-year figure at $60.7 million, up 1.16% from the prior year.
• Operating Expenses for Q1 2026 stood at $15.2 million, up from $15.0 million in the prior quarter.
• Over the last five years, Operating Expenses for MRMD reached as high as $16.0 million in Q1 2025 and fell as low as $9.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $13.6 million across 5 years, with a median of $14.5 million in 2024.
• On a YoY basis, Operating Expenses climbed as much as 61.47% in 2022 and fell as far as 10.95% in 2022.
• Year by year, Operating Expenses stood at $12.7 million in 2022, then grew by 17.16% to $14.9 million in 2023, then fell by 5.25% to $14.1 million in 2024, then gained by 6.39% to $15.0 million in 2025, then grew by 0.83% to $15.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $15.2 million in Q1 2026, $15.0 million in Q4 2025, and $14.8 million in Q3 2025.